Search
Close this search box.

We are creating some awesome events for you. Kindly bear with us.

CUHK Develops Microrobot

Image Credits: CUHK, Press Release

The Chinese University of Hong Kong (CUHK)’s cross-disciplinary research team developed a magnetic helical microrobot with endoscope-assisted delivery for biofilm eradication in ear tubes. The novel treatment procedure has been validated in a human cadaver ex vivo, which is a promising sign for clinical application. Study results have been published in the international journal Science Advances.

About 7% of children under the age of six have had otitis media with effusion. The fluid may resolve on its own within a few weeks but if the condition prevails, surgical treatment becomes necessary. Insertion of an ear tube into the tympanic membrane is a procedure to treat otitis media with effusion. In Hong Kong, it is common for adult or child patients to undergo an implant of an ear tube for otitis media with effusion.

Biofilm builds up in the ear tube over time and contributes to otorrhea, or drainage of fluid from the ear, and debris deposition, which in turn can cause blockages and recurring infections. For severely blocked ear tubes, surgeons must use specialised mechanical tools to clear the occlusion or replace the ear tube during endoscopy. This manoeuvre requires delicate expert skills to avoid injuries to the ossicular chain and tympanic membrane.

The Assistant Professor in the Department of Otorhinolaryngology, Head and Neck Surgery at CU Medicine explained that recurrent infections of ear refractory to antibiotic treatment and occlusion of the ear tube are complications related to biofilms after an operation.

Usually, antibiotics are used to prevent biofilm occlusion after surgery. However, they cannot prevent infection in the long term, and may lead to antimicrobial resistance. Some patients who suffer from ear tube occlusion require frequent tube replacement, which increases their physical and financial burden.

Hence, a research team with members from the Department of Mechanical and Automation Engineering at Faculty of Engineering, and the Department of Otorhinolaryngology, Head and Neck Surgery at CU Medicine joined hands to develop a magnetic helical microrobot with endoscope-assisted delivery for biofilm eradication in ear tube.

The treatment system consists of helical microrobot, endoscope, magnetic actuation unit with robotic arm, and catheter. Surgeons first use an endoscope to deliver the helical microrobot with a catheter into the ear tube. Then they can remotely actuate the microrobot by the programmed magnetic field in the ear tube to perform biofilm eradication.

A Professor from the Department of Mechanical and Automation Engineering said that microrobots have both chemical and mechanical methods of eradicating biofilm. The precision movement of the microrobot enables it to perform tasks harmlessly in a confined space with high accuracy while inducing no pain.

Meanwhile, the Associate Professor in the Department of Otorhinolaryngology, Head and Neck Surgery at CU Medicine stated that the novel treatment procedure has been validated in a human cadaver ex vivo, which is a promising sign for clinical application.

The invention can provide a more manageable alternative to the current treatment and alleviate the physical and psychological pressure from repetitive ear tube replacement. Looking ahead, the team will acquire more evidence about the safety and stability of the system to promote clinical application.

The Dean of Lee Kong Chian School of Medicine and CUHK’s Emeritus Professor noted that while biofilm has been known for quite some time, the clearance of biofilm has been an unsolved problem for decades. So far, no medication has proven to be useful in clearing the microbes once they are established on the surface as a layer. This study represents a breakthrough using both mechanical and chemical methods in the same modalities. Its application is not limited to ear tubes for otitis media: potentially it can be used in other medical devices or implants placed in the human body where biofilm infections can occur.

This study was supported by Research Grants Council, Innovation and Technology Commission, Chow Yuk Ho Technology Centre for Innovative Medicine, CUHK T Stone Robotics Institute, Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) – CUHK Joint Laboratory of Robotics and Intelligent Systems, and Multi-scale Medical Robotics Center under InnoHK.

PARTNER

Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.

PARTNER

CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.

PARTNER

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.

SUPPORTING ORGANISATION

SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.

PARTNER

HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 

PARTNER

IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.